Stifel Maintains Buy on Boston Scientific, Lowers Price Target to $55
Benzinga Newsdesk 6 days ago
Analyst RatingsNewsPrice TargetHot
Stifel analyst Rick Wise maintains Boston Scientific (NYSE:BSX) with a Buy and lowers the price target from $60 to $55.
Stifel analyst Rick Wise maintains Boston Scientific (NYSE:BSX) with a Buy and lowers the price target from $60 to $55.